Systemic stress-induced Th2 shift and its clinical implications

International Review of Neurobiology

Volumn 52, Issue , 2002, Pages 163-186

  Elenkov, Ilia J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW; STRESS; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; HUMANS; STRESS; TH1 CELLS; TH2 CELLS;

EID: 0036362767     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(02)52009-2     Document Type: Review

References (102)

1. Altare, F., Durandy, A., Lammas, D., Emile, J. F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E, Doffinger, R., Bernaudin, F., Jeppsson, O., Gollob, J. A., Meinl, E., Segal, A. W., Fischer, A., Kumararatne, D., and Casanova, J. L. (1998). Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280, 1432-1435.
2. Arnason, B. G., Brown, M., Maselli, R., Karaszewski, J., and Reder, A. (1988a). Blood lymphocyte β-adrenergic receptors in multiple sclerosis. Ann. N.Y. Acad. Sci. 540, 585-588.
3. Arnason, B. G., Noronha, A. B., and Reder, A. T. (1988b). Immunoregulation in rapidly progressive multiple sclerosis. Ann. N. Y. Acad. Sci. 540, 4-12.
4. Baker, A. J., and Fuller, R. W. (1995). Loss of response to β-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro. J. Leukoc. Biol. 57, 395-400.
5. Bamberger, C. M., and Bamberger, A. M. (2000). The peripheral CRF/urocortin system. Ann. N.Y. Acad. Sci. 917, 290-296.
6. Bamberger, C. M., Wald, M., Bamberger, A. M., Ergun, S., Beil, F. U., and Schulte, H. M. (1998). Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 83, 708-711.
7. Barnes, P., FitzGerald, G., Brown, M., and Dollery, C. (1980). Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. New Engl. J. Med. 303, 263-267.
8. Batuman, O. A., Ferrero, A., Cupp, C., Jimenez, S. A., and Khalili, K. (1995). Differential regulation of transforming growth factor β-1 gene expression by glucocorticoids in human T and glial cells .J. Immunol. 155, 4397-4405.
9. Besedovsky, H., Del Rey, A., Sorkin, E., and Dinarello, C. A. (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233, 652-654.
10. Besedovsky, H. O., del Rey, A. E., and Sorkin, E. (1983). What do the immune system and the brain know about each other? Immunol. Today 4, 342-346.
11. Beutler, B., Krochin, N., Milsark, I. W., Luedke, C., and Cerami, A. (1986). Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232, 977-980.
12. + lymphocytes. J. Immunol. 158, 5589-5595.
13. 2-Adrenoceptor subtype. Am. J. Respir. Cell Mol. Biol. 19, 400-407.
14. Boumpas, D. T., Chrousos, G. R, Wilder, R. L., Cupps, T. R., and Balow, J. F. (1993). Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann. Intern. Med. 119, 1198-1208.
15. Broug-Holub, E., and Kraal, G. (1996). Dose-and time-dependent activation of rat alveolar macrophages by glucocorticoids. Clin. Exp. Immunol. 104, 332-336.
16. Broug-Holub, E., Persoons, J. H., Schornagel, K., Mastbergen, S. C., and Kraal, G. (1998). Effects of stress on alveolar macrophages: A role for the sympathetic nervous system. Am. J. Respir. Cell Mol. Biol. 19, 842-848.
17. Buyon, J. P. (1998). The effects of pregnancy on autoimmune diseases. J. I.eukoc. Biol. 63, 281-287.
18. Buyon, J. P., Nelson, J. L., and Lockshin, M. D. (1996). The effects of pregnancy on autoimmune diseases. Clin. Immunol. Immunopathol. 78, 99-104.
19. Cadet, P., Rady, P. L., Tyring, S. K., Yandell, R. B., and Hughes, T. K. (1995). Interleukin-10 messenger ribonucleic acid in human placenta: Implications of a role for interleukin-10 in fetal allograft protection. Am. J. Obslel. Gynecol. 173, 25-29.
20. Chelmicka-Schorr, E., Kwasniewski, M. N., Thomas, B. E., and Arnason, B. G. (1989). The β-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 25, 203-207.
21. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., and Blav, J. Y (1997). The host-tumor immune conflict: From immunosuppression to resistance and destruction. Immunol. Today 18, 493-497.
22. Chrousos, G. P. (1995). The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation [see comments]. New Engl. J. Med. 332, 1351-1362.
23. Church, M. K., Lowman, M. A., Robinson, C., Holgate, S. T., and Benyon, R. C. (1989). Interaction of neuropeptides with human mast cells. Int. Arch. Allergy Appl. Immunol. 88, 70-78.
24. Clerici, M., Bevilacqua, M., Vago, T., Villa, M. L., Shearer, G. M., and Norbiato, G. (1994). An immunoendocrinological hypothesis of HIV infection [see comments]. Lancet 343, 1552-1553.
25. Cohen, S., Tyrrell, D. A., and Smith, A. P. (1991). Psychological stress and susceptibility to the common cold [see comments]. New Engl. J. Med. 325, 606-612.
26. Cole, S. W., Korin, Y D., Fahey, J. L., and Zack, J. A. (1998). Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J. Immunol. 161,610-616.
27. Colombo, M. P., Vagliani, M., Spreafico, E, Parenza, M., Chiodoni, C., Melani, C., and Stoppacciaro, A. (1996). Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res. 56, 2531-2534.
28. Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., and Moreau, T. (1998). Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. New Engl. J. Med. 339, 285-291.
29. 2-adrenoceptor agonists [see comments]. Clin. Exp. Allergy 25, 304-311.
30. + lymphocytes by inhibiting IL-12 production. J Immunol. 160, 2231-2237.
31. Elenkov, I. J., and Vizi, E. S. (1991). Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology 30, 1319-1324.
32. Elenkov, I. J., Haskó, G., Kovacs, K. J., and Vizi, E. S. (1995). Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α-and β-adrenergic drugs in mice. J. Neuroimmunol. 61, 123-131.
33. Elenkov, I. J., Papanicolaou, D. A., Wilder, R. L. and Chrousos, G. P. (1996). Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc. Assoc. Am. Physicians. 108, 374-381.
34. Elenkov, I. J., Hoffman, J., and Wilder, R. L. (1997). Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol. Med. Today 3, 379-383.
35. Elenkov, I. J., Webster, E., Papanicolaou, D. A., Fleisher, T. A., Chrousos, G. P., and Wilder, R. L. (1998). Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J. Immunol. 161, 2586-2593.
36. Elenkov, I. J., Webster, E. L., Torpy, D. J., and Chrousos, G. P. (1999). Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: Acute and chronic effects. Ann. N.Y. Acad. Sci. 876, 1-11.
37. Elenkov, I. J., Wilder, R. L., Chrousos, G. P., and Vizi, E. S. (2000). The sympathetic nerve— An integrative interface between two supersystems: The brain and the immune system. Pharmacol. Rev. 52, 595-638.
38. Elenkov, I. J., Wilder, R. L., Bakalov, V. K., Link, A. A., Dimitrov, M. A., Fisher, S., Crane, M., Kanik, K. S., and Chrousos, G. P. (2001). IL-12, TNF-α, and hormonal changes during late pregnancy and early postpartum: Implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab. 86, 4933-4938.
39. Engstad, C. S., Lund, T., and Osterud, B. (1999). Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets. Thromb. Haemosl. 81, 139-145.
40. Fearon, D. T., and Locksley, R. M. (1996). The instructive role of innate immunity in the acquired immune response. Science 272 50-53.
41. Felten, D. L., Felten, S. Y, Bellinger, D. L., and Lorton, D. (1992). Noradrenergic and peptidergic innervation of secondary lymphoid organs: Role in experimental rheumatoid arthritis. Eur. j. Clin. Invest. 22 Suppl 1, 37-41.
42. Foreman, J. C. (1987). Substance P and calcitonin gene-related peptide: Effects on mast cells and in human skin. Int. Arch. Allergy Appl. Immunol. 82, 366-371.
43. Gayo, A., Mozo, L., Suarez, A., Tunon, A., Lahoz, C., and Gutierrez, C. (1998). Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. J. Neuroimmunol. 85, 122-130.
44. Geenen, R., Godaert, G. L., Jacobs, J. W., Peters, M. L., and Bijlsma, J. W. (1996). Diminished autonomic nervous system responsiveness in rheumatoid arthritis of recent onset. J. Rheumatol. 23, 258-264.
45. Greig, P C., Herbert, W. N., Robinette, B. L, and Teot, L. A. (1995). Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am. J. Obstet. Gynecol. 173, 1223-1227.
46. Haraguchi, S., Good, R. A., James-Yarish, M., Cianciolo, G.J., and Day, N. K. (1995). Induction of intracellular cAMP by a synthetic retroviral envelope peptide: A possible mechanism of immunopaihogenesis in retroviral infections. Proc. Nall. Acad. Sci. USA 92, 5568-5571.
47. 2-adrenoreceptors on plasma levels of tumour necrosis factor-α, interlcukin-6 and corticosterone induced by bacterial lipopolysaccharide. J. Endocr. 144, 457-462.
48. Haskó, G., Szabo, C., Nemeth, Z. H., Salzman, A. L., and Vizi, E. S. (1998). Stimulation of β-adrenoceptors inhibits endotoxin-induced IE-12 production in normal and IL-10 deficient mice. J. Neuroimmunol. 88, 57-61.
49. Hellstrand, K., and Hermodsson, S. (1989). An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int. Arch. Allergy Appl. Immunol. 89, 334-341.
50. Ho, W.Z., Stavropoulos, G., Lai, J. P., Hu, B. F., Magafa, V., Anagnostides, S., and Douglas, S. D. (1998). Substance P G-terminal octapeptide analogues augment tumor necrosis factor-a release by human blood monocyics and macrophages. J. Neuroimmunol 82, 126-132.
51. Irwin, M. (1994). Stress-induced immune suppression: Role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv. Neuroimmunol. 4, 29-47.
52. Joe, B., Griffiths, M. M., Remmers, E. F., and Wilder, R. L. (1999). Animal models of rheumatoid arthritis and related inflammation. Cun: Rheumatol. Rep. 1, 139-148.
53. Kaplanski, G., Porai, R., Aiura, K., Erban, J. K., Gelfand, j. A., and Dinarello, C. A. (1993). Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81, 2492-2495.
54. Karalis, K., Sano, H., Redwine, J., Listwak, S., Wilder, R. L., and Chrousos, G. P. (1991). Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254, 421-423.
55. Karaszewski, J. W., Reder, A. T., Maselli, R., Brown, M., and Arnason, B. G. (1990). Sympathetic skin responses are decreased and lymphocyte β-adrenergic receptors are increased in progressive multiple sclerosis. Ann. Neurol. 27, 366-372.
56. Karaszewski, J. W., Reder, A. T., Anlar, B., and Arnason, G. W. (1993). Increased high affinity β-adrenergic receptor densities and cyclic AMP responses ofCD8 cells in multiple sclerosis. J. Neuroimmunol. 43, 1-7.
57. Kavelaars, A., van, D.P., Zijlstra, J., and Heijnen C. J. (1997). β2-adrencrgic activation enhances inlerlcukin-8 production by human monocytes. J. Neuroimmunol. 77, 211-216.
58. Khamashta, M. A., Ruiz-Irastorza, G., and Iughes, G. R. (1997). Systemic Inpus erythematosus lares during pregnancy. Rheum. Dis. Clin. North Am. 23, 15-30.
59. Kincy-Cain, T., and Bost, K. L. (1997). Substance P-induced IL-12 production by murine macrophages. J. Immunol. 158, 2334-2339.
60. Kino, T., Gragerov, A., Kopp, J. B., Stauber, R. II., Pavlakis, G. N., and Chrousos, G. P. (1999). The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J. Exp. Med. 189, 51-62.
61. Kohno, M., Kawahito, Y, Tsubonchi, Y, Hashiramolo, A., Yamada, R., Irioue, K. I., Kusaka, Y., Kubo, L, Elenkov, I. J., Chrousos, G. P., Kondo, M., and Sano, H. (2001). Uroconin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: Relation lo inflammatory activity. J. Clin. Endocrinol. Metal. 86, 4344-4352.
62. Kovacs, K. J., and Elenkov, I. J. (1995). Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. ]. Neuroendocrinal. 7, 15-23.
63. Lagier, B., Lebel, B., Bousquet, J., and Pene J. (1997). Different modulation by histamine of IL-4 and interferon-γ (IFN-γ) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin. Exp. Immunol. 108, 545-551.
64. Lerner, B. H. (1996). Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes, 1949-1961. Ann. Intern. Med. 124, 673-680.
65. Le Tulzo, Y, Shenkar, R., Kaneko, D., Moine, P., Fantuzzi, G., Dinarello, C. A., and Abraham, E. (1997). Hemorrhage increases cytokine expression in lung mononuclear cells in mice: Involvement of catecholamines in nuclear factor-κB regulation and cytokine expression. J. Clin. Invest. 99, 1516-1524.
66. Levenstein, S., Ackerman, S., Kiecolt-Glaser, J. K., and Dubois, A. (1999). Stress and peptic ulcer diseasc.JAMA 281, 10-11.
67. + T cells. Anticancer Res. 17, 4259-4268.
68. Linden, A. (1996). Increased interleukin-8 release by β-adrenoceptor activation in human transformed bronchial epithelial cells. Br. J. Pharmacol. 119, 402-406.
69. Lombardi, M. S., Kavelaars, A., Schedlowski, M., Bijlsma, J. W., Okihara, K. L., Van de, P. M., Ochsmann, S., Pawlak, C., Schmidt, R. E., and Heijnen, C. J. (1999). Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. EASEBJ. 13, 715-725.
70. Lorton, D., Bellinger, D., Duclos, M., Felten, S. Y, and Felten, D. L. (1996). Application of 6-hydroxydopamine into the fatpads surrounding the draining lymph nodes exacerbates adjuvant-induced arthritis./. Neuroimmunol. 64, 103-113.
71. Lotz, M., Vaughan, J. H., and Carson, D. A. (1988). Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241, 1218-1221.
72. Mackenzie, F. J., Leonard, J. P., and Cuzner, M. L. (1989). Changes in lymphocyte ^-adrenergic receptor density and noradrenaline content of the spleen are early indicators of immune reactivity in acute experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol. 23, 93-100.
73. 2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: Mechanisms of action. J. Immunol. 162, 6278-6283.
74. Marzi, M., Vigano, A., Trabattoni, D., Villa, M. L., Salvaggio, A., Clerici, E., and Clerici, M. (1996). Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106, 127-133.
75. Matsumoto, S. (1995). Cimetidine and survival with colorectal cancer. Lancet 346, 115.
76. Miller, L. E., Justen, H. P., Scholmerich, J., and Straub, R. H. (2000). The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied byincreased norepinephrine release from synovial macrophages. EASES J. 14, 2097-2107.
77. Mosmann, T. R., and Sad, S. (1996). The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
78. O’Sullivan, S. T., Lederer, J. A., Horgan, A. F., Chin, D. H., Mannick, J. A., and Rodrick, M. L. (1995). Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection [see comments]. Ann. Surg. 222, 482-490.
79. 2-Agonists prevent Thl development by selective inhibition of interleukin 12. J Clin. Invest. 100, 1513-1519.
80. Petri, M. (1997). Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. North Am. 23, 1-13.
81. Petri, M., Howard, D., and Repke, J. (1991). Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 34, 1538-1545.
82. + T cells in vitro. J. Immunol. 156, 2406-2412
83. Sakamoto, S., Fukushima, A., Ozaki, A., Ueno, H., Kamakura, M., and Taniguchi, T. (2001). Mechanism for maintenance of dominant T helper 1 immune responses in Lewis rats. Microbiol. Immunol. 45, 373-381.
84. 2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. J. Immunol. 158, 4200-4210.
85. Segal, B. M., Dwyer, B. K., and Shevach, E. M. (1998). An interleukin (IL)-10/IL-12 immuno-regulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187, 537-546.
86. Shakhar, G., and Ben-Eliyahu, S. (1998). In vivo β-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J. Immunol. 160, 3251-3258.
87. Spengler, R. N., Allen, R. M., Remick, D. G., Stricter, R M., and Kunkel, S. L. (1990). Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 145, 1430-1434.
88. Straub, R. H., and Cutolo, M. (2001). Involvement of the hypothalamic-pituitary-adrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis: Viewpoint based on a systemic pathogenetic role. Arthritis Rheum. 44, 493-507.
89. Sun, B., Sun, S. H., Chan, C. C., and Caspi, R. R. (2000). Evaluation of m wwcvtokine expression in EAU-susceptible and resistant rats: A role for IL-10 in resistance? Exp. Eye Res. 70, 493-502.
90. Tabardel, Y., Duchateau, J., Schmartz, D., Marecaux, G., Shahla, M., Barvais, L., LeClerc, J. L., and Vincent, J. L. (1996). Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 119, 76-80.
91. Theoharides, T. C., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J. J., Webster, E., and Chrousos, G. P. (1995). Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology 136, 5745-5750.
92. Theoharides, T. C., Singh, L. K., Boucher, W., Pang, X., Letourneau, R., Webster, E., and Chrousos, G. (1998). Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139, 403-413.
93. Trinchieri, G. (1995). Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
94. Udelsman, R., Gallucci, W. T., Bacher, J., Loriaux, D. L., and Chrousos, G. P. (1986). Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. Peptides 7, 465-471.
95. van der Poll, T., Barber, A. E., Coyle, S. M., and Lowry, S. F. (1996). Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia—A clinical research center study. J. Clin. Endocrinol. Metab. 81, 3604-3606.
96. Vizi, F. S., Orso, E., Osipenko, O. N., Haskó, G., and Elenkov, I. J. (1995). Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68, 1263-1276.
97. Wiegmann, K., Muthyala, S., Kim, D. H., Arnason, B. G., and Chclmicka-Schorr, E. (1995). β-Adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol. 56, 201-206.
98. Wilder, R. L. (1995). Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13, 307-338.
99. Wilder, R. L., and Elenkov, I. J. (1999). Hormonal regulation of tumor necrosis factor-α, interleukin-12 and interleukin-10 production by activated macrophages. A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus? Ann. N.Y. Acad. Sci 876, 14-31.
100. Woiciechowsky, C., Asadullah, K, Nestler, D., Eberhardt, B., Platzer, C., Schoning, B., Glockner, F., Lanksch, W. R., Volk, H. D., and Docke, W. D. (1998). Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 4, 808-813.
101. Wu, C. Y, Wang, K, McDyer, J. F., and Seder, R. A. (1998). Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161, 2723-2730
102. Zieg, G., Lack, G., Harbeck, R. J., Gelfand, E. W., and Leung, D. Y (1994). In vivo effects of glucocorticoids on IgE production. J. Allergy Clin. Immunol. 94, 222-230.